Preclinical pharmacokinetic comparison of glucose-125I-Tyr3-octreotate with DOTA-125I-Tyr3-octreotate

Abstrakt

125I-gluc-tate exhibited higher uptake in somatostatin receptor-rich organs with lower uptake in the kidney in comparison with 125In-DOTA-tate. Radiolabelled gluc-tate may be promising ligand for targeted radiotherapy when labeled with short living 211At